Avandia, a Case of Deja Vu all over again
Similar Posts
NHLBI director Dr. Lenfant is Retiring
NHLBI director Dr. Lenfant is Retiring Thu, 3 Jul 2003 The retirement of Dr. Claude Lenfant, director of the National Heart, Lung, and Blood Institute (NHLBI) was announced today. Not mentioned in the press release is the heated controversy surrounding two clinical trials sponsored by the NHLBI, conducted by the…
Pills Become Addictive Study Aid For Students (Adderall)
Amphetamines work like Cocaine–first and foremost, they are addictive. The psychostimulant drugs prescribed for millions of American children labeled ADHD, are amphetamines and are, therefore, addictive.
Article
October 14, 2005 link to pdf of original letter Dr. Russell Katz Director, Neuropharmacological Drug Products Food and Drug Administration, FDA 120 1451 Rockville Pike, Room 4037 Rockville, MD 20852 Re: FDA Neurontin Safety Analyses Dear Dr. Katz: Due to the continued public danger facing a substantial class of…
FDA Suspends ADHD Drug Safety Study-Approves Risperdal for Autistic Children Without Public Hearing
Two actions by the FDA last week demonstrate where the agency’s priority lies—and that priority is NOT to protect public safety, NOT to protect children’s safety. FDA’s priority—as demonstrated by its actions—is approval of new drugs or approval for expanded even dubious uses of patented drugs.
Big Pharma: The Fool’s Gold that Heals_New Book
Big Pharma by Jacky Law reveals that in essence, most of the pharmaceutical industry’s claims are false; it is not the drug, but the placebo effect whose potency deserves almost all of the credit for any health improvement:
InfoMail for March 14, 2002
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav March 14, 2002 Whistle-Blower SaysMarketers Broke the Rules to Push a Drug (Neurontin) FYI The New York Times reports that court papers in a civillawsuit "may provide a…